Could stem cell- or molecular-based treatment be the solution to temporomandibular joint disorders?
29 Jun 21
A new study, led by Amy Merrill-Brugger, could lead to new treatments for the common disorder.
OUR JAWS ALLOW US TO TALK, chew, swallow, sing and even yawn. All these activities require the temporomandibular joints, which connect the lower jaw to the base of the skull and drive its movement up and down and side to side.
When disorders in temporomandibular joints arise — a commonly occurring condition that the National Institutes of Health estimate affects between 5 and 12 percent of the American population — it can cause pain, discomfort and disability.
There is not a lot known about what causes temporomandibular joint disorders (TMD), but a new study led by Associate Professor Amy Merrill-Brugger PhD ’05 could change that, even giving healthcare providers new stem cell- and molecular-based interventions to promote tissue repair and regeneration in patients suffering from TMD.
In the five-year study, funded by a $2.3-million grant from the National Institutes of Dental and Craniofacial Research, Merrill-Brugger and her team will study embryonic development of the tissue connecting tendons to bone.
“Tendon and bone are connected by a specialized connective tissue called the enthesis,” Merrill-Brugger explained. “The enthesis plays a very important role in joint mobility because it allows muscles to move bones. We hope to discover how entheses that promote jaw movement form during embryonic development.”
Damage to this connective tissue (enthesis) can result from either physical injury or disease and is linked to TMD, she added.
“By identifying the cells and genes that build jaw entheses in development, this study has the potential to guide novel strategies to promote tissue repair and regeneration in temporomandibular disorders.”
Merrill-Brugger earned a bachelor’s degree in molecular, cellular and developmental biology from the University of California, Santa Barbara and a PhD in biochemistry and molecular biology from USC, before embarking on an independent academic career in biomedical research.
“I love how science demands imagination and innovation, while also offering the thrill of discovery and an endless potential to improve the health and well-being of others,” she said.
Merrill-Brugger joined Ostrow in 2010 as an assistant professor with a dual appointment with the Keck School of Medicine of USC. She was promoted to associate professor with tenure in 2018.
This year, the Herman Ostrow School of Dentistry of USC was ranked No. 4 in research funding by the National Institute of Dental and Craniofacial Research, thanks in part to grants like this earned by Merrill-Brugger.
“Competition for funding is intense,” she said. “Having our work and ideas recognized by the NIDCR with this grant is truly energizing.”
Research reported in this publication was supported by the National Institute of Dental & Craniofacial Research of the National Institutes of Health under Award Number R01DE029850. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Jian Xu hopes to better understand the mechanisms behind environmental toxins increasing the occurrence of birth defects in order to develop new treatments or even prevent craniofacial birth defects. NEARLY 120,000 BABIES WILL BE BORN with birth defects this year. While there are a number of causes — genetics and chromosomal issues, infections during pregnancy, […]
Ostrow adds 3-D intraoral scanning training to orthodontics module for DDS and ASPID students. THROUGHOUT JUNE, THE ADVANCED ORTHODONTICS CLINIC on the Norris Dental Science Center’s third floor was abuzz with activity. Over the course of five half-day sessions, more than 180 students from the DDS Class of 2024 and the ASPID Class of 2023 […]
Ostrow researchers awarded five-year grant to investigate how a popular antidepressant interacts with pregnant women’s genes to cause craniofacial birth defects NEARLY 25 PERCENT OF PREGNANT WOMEN TAKE CITALOPRAM — a selective serotonin reuptake inhibitor (SSRI) that works by boosting levels of the “feel good” hormone serotonin. While the antidepressant might have positive effects on […]
The prestigious five-year training grants are meant to support tomorrow’s leading thinkers in craniofacial research as they launch their academic careers. OSTROW HAS BEEN AWARDED TWO RESEARCH GRANTS from the National Institute of Dental and Craniofacial Research to support nine PhD students and postdoctoral fellows, giving USC the distinction of being just one of […]
The discovery, made by an Ostrow-led research team, could soon improve the lives of human beings with critical size cranial defects. EVERY YEAR, SURGEONS PERFORM MORE THAN 5,000 CRANIOPLASTIES (surgeries that restore cranial defects) on patients who have experienced critical size cranial defects resulting from congenital defects, head trauma or tumor removals. Traditional materials used […]